Drugdiscovery >> Publications >> News
5420
Views
Preclinical study gives hope for potential  IPS cell therapy in Parkinson disease - drugdiscovery.com
Preclinical study gives hope for potential IPS cell therapy in Parkinson disease - drugdiscovery.com


Researchers at the Kyoto University have discovered that autologous transplantation of dopaminergic neurons prepared from induced pluripotent stem cells ( iPS) into the brains of cynomolgus monkeys produced almost no immune reaction and resulted in viable neural cells.
Read More >>


Tags: stem cells, therapy, iPS, induced pluripotent stem cells, autologous transplantation, neurons, Parkinson disease - September 30, 2013
Related Articles
4656
Views
Parkinson disease: there may be two different forms of the disease Parkinson disease: there may be two different forms of the disease
A discovery of the existence of two different types of alpha-synuclein aggregates, which differ in their toxicity for dopaminergic neurons, may explain varying symptoms of Parkinson’s disease from o Read More >>

Tags: Parkinson disease, parkinsons, research, discovery, alpha synuclein

5576
Views
Potential new target  for cancer therapy discovered Potential new target for cancer therapy discovered
Researchers at Spanish National Cancer Research Center have decoded a new mechanism that regulates cell division, and identified its key molecule, Greatwall, as a potential target for oncology treatme Read More >>

Tags: cell division, new mechanism, Greatwall, potential target, oncology, cancer, treatment, research, discovery

4429
Views
Potential new strategy for improving stem cell therapy in cardiovascular diseases Potential new strategy for improving stem cell therapy in cardiovascular diseases
Researchers have discovered that encapsulating mesenchymal stem cells in capsules made of alginate, a gel-like substance, makes them more effective as regenerative therapy after heart attack in an an Read More >>

Tags: stem cell therapy, cardiovascular diseases, MSC, mesenchymal stem cells, heart attack, research

4566
Views
Drug candidate prevents the development of type 1 diabetes - a preclinical study Drug candidate prevents the development of type 1 diabetes - a preclinical study
Compugen’s Fc fusion protein drug candidate CGEN-15001 has been shown to be highly efficient in preventing the development of the disease in an animal model of autoimmune type 1 diabetes. Read More >>

Tags: Compugen, Fc fusion protein, drug candidate, CGEN-15001, prevention, autoimmune, type 1 diabetes

4925
Views
New hope for Crohn’s disease patients New hope for Crohn’s disease patients
A team of scientist at NUI Maynooth has discovered that levels of a protein called Pellino3 are dramatically reduced in Crohn’s disease patients. This protein might provide basis for new diagnostic Read More >>

Tags: Crohn’s disease, Pellino3, new treatment, diagnosis

2797
Views
New protein knowledge offers hope for better cancer treatment New protein knowledge offers hope for better cancer treatment
Researchers have developed an advanced method for identifying the proteins which are modified with ADP-ribosylation - a biological modification crucial for cell’s, including certain cancer cells, se Read More >>

Tags: ADP-ribosylation, PARP, inhibitors, self- repair, DNA repair, cancer cell

6637
Views
Lung cancer: potential new marker for early diagnosis identified Lung cancer: potential new marker for early diagnosis identified
According to a recent study, a protein called isocitrate dehydrogenase shows potential to be used as an early, noninvasive diagnostic biomarker of non-small cell lung cancers. It also may possibly be Read More >>

Tags: isocitrate dehydrogenase, marker, new, noninvasive diagnostic biomarker, non-small cell lung cancers

1251
Views
FDA Approvals are scrutinized in study FDA Approvals are scrutinized in study
Altough being accepted by FDA, it is still not sure that a drug is safe and effective. A new study shows that many of the drugs, accepted by FDA, are not examined fully and some are even dangerous. Read More >>

Tags: FDA, approval, medicine, study

4675
Views
A potential new drug target for high-grade meningiomas A potential new drug target for high-grade meningiomas
Researchers from Johns Hopkins have found that a protein called NY-ESO-1 is present in nearly 100 percent of high-grade meningiomas, the most common form of brain tumor. This makes it a potential ne Read More >>

Tags: meningiomas, protein, NY-ESO-1, clinical trial, drug target, cancer therapy

3765
Views
Combining gene therapy and stem cell treatment for wound healing Combining gene therapy and stem cell treatment for wound healing
Researchers have menaged to quicken wound healing in elderly mice with diabetic wounds by using gene therapy combined with an infusion of stem cells. This discovery could potentially lead to better t Read More >>

Tags: gene therapy, stem cells, treatment, wound healing, wounds, research

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013